Der Calypte-Thread
13.05.13 0,0031 0,0035 0,0028 0,0035 $ 149.285 485
GrB
15:44:45 0,0035 $ 15.000
15:30:14 0,0028 $ 100
_____________________
bestellt und bekommen ..sehr schön
Zeit Kurs Stück
18:43:45 0,0035 $ 50.000
18:34:52 0,0035 $ 20.000
15:30:39 0,003 $ 500
15:30:17 0,0035 $ 20.000
15:30:15 0,0035 $ 6.000
GrB
Zeit Kurs Stück
19:38:35 0,004 $ 14.000
19:38:21 0,004 $ 36.254
19:37:12 0,004 $ 30.000
19:35:09 0,004 $ 43.559
19:34:58 0,004 $ 50.000
19:29:48 0,004 $ 15.687
19:29:40 0,004 $ 65.000
19:28:43 0,0039 $ 75.000
19:28:39 0,004 $ 45.000
_____________________
weil wir Rackers sind ..die nach mehr streben ..und nicht einfach sinnlos Träume verleben
30.05.13 0,0035 0,0035 0,0029 0,0035 $ 232.000 726
.......geht voll durch hier
20:00:10 0,0035 $ 70.000
19:37:50 0,0035 $ 30.000
19:37:41 0,0034 $ 10.000
19:30:50 0,0035 $ 30.000
17:10:35 0,0028 $ 500
16:03:23 0,0028 $ 1.300
GrB
12.06.13 0,0034 0,0035 0,0034 0,0034 $ 264.944 785
GrB
16:21:25 0,006 $ 25.000
16:16:55 0,006 $ 20.005
15:31:21 0,005 $ 10.000
15:30:58 0,005 $ 10.000
GrB
Satz 07-08
Datum Erster Hoch Tief Schluss Stücke Volumen
07.08.13 0,006 0,006 0,006 0,006 $ 4.500 27
GrB
Zeit Kurs Stück
18:05:16 0,006 $ 25.000
15:36:38 0,005 $ 11.000
____________________
GLÜCKWUNSCH
Katja & buran
Branche Biotechnologie
Herkunft USA
Website www.calypte.com
Aktienanzahl 700,2 Mio. (Stand: 14.04.13)
Marktkap. 3,78 Mio. $
GrB
buran und danke und weitermachen
Date Open High Low Close/Last Volume
09/06/2013 0.0065 0.0075 0.0055 0.0062 19,137
09/04/2013 0.0044 0.0068 0.0042 0.0065 175,000
08/28/2013 0.006 0.0068 0.0035 0.0042 493,733
08/21/2013 0.005 0.006 0.0045 0.006 23,500
08/14/2013 0.0045 0.0055 0.0045 0.005 33,800
08/07/2013 0.0051 0.006 0.0046 0.006 4,500
07/31/2013 0.006 0.007 0.0046 0.006 125,611
07/24/2013 0.006 0.009 0.005 0.0055 49,170
07/17/2013 0.003 0.006 0.003 0.006 218,000
07/10/2013 0.0035 0.005 0.003 0.005 30,209
07/03/2013 0.005 - - 0.005 0
06/26/2013 0.0035 - - 0.005 0
06/19/2013 0.0034 - - 0.005 0
06/12/2013 0.0035 0.004 0.0028 0.0034 264,944
06/05/2013 0.0035 0.004 0.0028 0.0035 22,000
05/29/2013 0.0033 0.0035 0.0027 0.0035 59,480
05/22/2013 0.0035 0.004 0.0028 0.004 430,500
05/15/2013 0.0039 0.004 0.0028 0.0035 145,100
05/08/2013 0.0035 0.004 0.003 0.004 515,200
05/01/2013 0.0065 0.007 0.003 0.003 960,000
04/24/2013 0.007 0.0075 0.005 0.0065 29,600
04/17/2013 0.006 0.01 0.0035 0.0075 158,066
04/10/2013 0.004 - - 0.006 0
04/03/2013 0.007 0.007 0.0033 0.0045 44,000
03/27/2013 0.0043 0.007 0.0032 0.007 10,978
03/20/2013 0.004 0.0045 0.003 0.0031 239,300
03/13/2013 0.006 0.006 0.004 0.0041 2,366,985
03/06/2013 0.003 0.007 0.003 0.004 1,119,796
02/27/2013 0.0028 0.0035 0.0026 0.0035 707,200
02/20/2013 0.0028 0.003 0.0028 0.0028 15,000
02/13/2013 0.0025 0.0035 0.0025 0.003 2,001
02/06/2013 0.0035 - - 0.003 0
01/30/2013 0.0027 0.0035 0.0025 0.0025 333
01/23/2013 0.0034 - - 0.0027 0
01/16/2013 0.0022 0.0035 0.0022 0.0025 210,550
01/09/2013 0.0032 0.0032 0.0022 0.0029 36,800
01/02/2013 0.0018 0.003 0.0013 0.0022 5,633
http://charting.nasdaq.com/ext/...0-120122007-03NA000000CBMC&SF:4|5-FREQ=7-WD=539-HT=395--XTBL-
Founded in 1988, Calypte is a pioneer in non-blood-based HIV antibody testing. We’re the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot.Today, our Aware™ family of rapid oral fluid HIV tests offers unrivalled HIV 1/2 testing flexibility in a non-laboratory setting.
Calypte is also the licensed manufacturer of a quantitative enzyme immunoassay developed by the U.S. Centers for Disease Control and Prevention (CDC) that can discriminate between recent and established HIV-1 infections. Designed for use in epidemiology, the Aware™ BED™ EIA is a practical way to determine HIV-1 incidence (the rate of new infections). Because it uses cross-sectional rather than longitudinal sampling and is based on direct biomarker evaluation, the BED EIA can provide incidence information much more rapidly than traditional methods such as cohort studies. Since its introduction in 2004 (formerly under the name BED HIV-1 Incidence EIA), the Aware™ BED™ EIA has gained widespread favor with government institutions and HIV intervention programs worldwide as a tool for better allocating resources, measuring program success and targeting HIV hot spots.
Working through a network of national and regional distributors Calypte continues to broaden the reach of its products. We plan to launch a new line of rapid HIV antibody tests in the United States and other developed nations using a novel lateral flow platform technology and we remain committed to bringing new products to developing regions where the need is acute for accurate, innovative HIV testing methods.
To meet this demand with maximum quality and efficiency, we’ve added manufacturing capacity through a contract with an ISO-certified manufacturer in Thailand and a cGMP certified manufacturer in the USA.
Publicly held, Calypte trades on the OTCBB under the symbol “CBMC.”
http://www.calypte.com/aboutus.html
GrB
19:39:50 0,005 $ 63.994
19:30:11 0,005 $ 50.000
16:45:35 0,005 $ 26.000
16:41:33 0,0045 $ 17.100
15:30:17 0,005 $ 10.000
GrB
18:24:07 0,005 $ 20.000
17:31:05 0,005 $ 20.000
16:16:05 0,005 $ 58.000
15:42:16 0,005 $ 50.000
15:30:10 0,005 $ 120.000
_____________________
..Mutti iss stolz auf Euch
buran,Die Börsen Mutti
Prev Close: 0.01
Open: 0.01
Bid: N/A
Ask: N/A
1y Target Est: 0.20
Beta: N/A
Next Earnings Date: 23-Sep-13
Day's Range: 0.01 - 0.01
52wk Range: N/A
Volume: 268,000
Avg Vol (3m): N/A
Market Cap: 3.50M
P/E (ttm): N/A
EPS (ttm): -0.00
Div & Yield: N/A (N/A
http://finance.yahoo.com/q?s=CBMC&ql=1